Abstract
In the current decade, advances in health care are attracting widespread interest due to their contributions to people longer surviving and fitter lives. Alzheimer’s disease (AD) is the commonest neurodegenerative and dementing disease. The monetary value of caring for Alzheimer’s disease patients is involved to rise dramatically. The necessity of having a computer-aided system for early and accurate AD classification becomes crucial. Deep-learning algorithms have notable advantages rather than machine learning methods. Many recent research studies that have used brain MRI scans and convolutional neural networks (CNN) achieved promising results for the diagnosis of Alzheimer’s disease. Accordingly, this study proposes a CNN based end-to-end framework for AD-classification. The proposed framework achieved 99.6%, 99.8%, and 97.8% classification accuracies on Alzheimer’s disease Neuroimaging Initiative (ADNI) dataset for the binary classification of AD and Cognitively Normal (CN). In multi-classification experiments, the proposed framework achieved 97.5% classification accuracy on the ADNI dataset.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Notes
A complete listing of ADNI investigators can be found at: ”http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf.”
References
Aderghal K, Khvostikov A, Krylov A, Benois-Pineau J, Afdel K, Catheline G (2018) Classification of alzheimer disease on imaging modalities with deep CNNs using cross-modal transfer learning. In: 2018 IEEE 31st international symposium on computer-based medical systems (CBMS). IEEE. https://doi.org/10.1109/cbms.2018.00067
Altaf T, Anwar SM, Gul N, Majeed MN, Majid M (2018) Multi-class alzheimer’s disease classification using image and clinical features. Biomed Signal Process Control 43:64–74
Asim Y, Raza B, Malik AK, Rathore S, Hussain L, Iftikhar MA (2018) A multi-modal, multi-atlas-based approach for alzheimer detection via machine learning. Int J Imaging Syst Technol 28(2):113–123
Baldacci F, Lista S, O’Bryant SE, Ceravolo R, Toschi N, Hampel H, Initiative APM et al (2018) Blood-based biomarker screening with agnostic biological definitions for an accurate diagnosis within the dimensional spectrum of neurodegenerative diseases. In: Biomarkers for alzheimer’s disease drug development. Springer, pp 139–155
Basaia S, Agosta F, Wagner L, Canu E, Magnani G, Santangelo R, Filippi M, Initiative ADN et al (2019) Automated classification of alzheimer’s disease and mild cognitive impairment using a single MRI and deep neural networks. NeuroImage Clin 21:101645
Basheera S (2020) A novel CNN based alzheimer’s disease classification using hybrid enhanced ICA segmented gray matter of MRI. Comput Med Imaging Graph 18:101713
Beheshti I, Demirel H, Matsuda H, Initiative ADN et al (2017) Classification of alzheimer’s disease and prediction of mild cognitive impairment-to-alzheimer’s conversion from structural magnetic resource imaging using feature ranking and a genetic algorithm. Comput Biol Med 83:109–119
Beheshti I, Maikusa N, Matsuda H, Demirel H, Anbarjafari G (2017) Histogram-based feature extraction from individual gray matter similarity-matrix for alzheimer’s disease classification. J Alzheimers Dis 55(4):1571–1582
Bottou L (2010) Large-scale machine learning with stochastic gradient descent. In: Proceedings of (COMPSTAT’2010). Springer, pp 177–186
Braak H, Braak E (1995) Staging of alzheimer’s disease-related neurofibrillary changes. Neurobiol Aging 16(3):271–278
Bruscoli M, Lovestone S (2004) Is MCI really just early dementia? A systematic review of conversion studies. Int Psychogeriatr 16(2):129–140
Choi JY, Lee B (2020) Combining of multiple deep networks via ensemble generalization loss, based on MRI images, for alzheimer’s disease classification. IEEE Signal Process Lett 27:206–210
Delacourte A, David JP, Sergeant N, Buee L, Wattez A, Vermersch P, Ghozali F, Fallet-Bianco C, Pasquier F, Lebert F et al (1999) The biochemical pathway of neurofibrillary degeneration in aging and alzheimer’s disease. Neurology 52(6):1158–1158
Duraisamy B, Shanmugam JV, Annamalai J (2018) Alzheimer disease detection from structural MR images using FCM based weighted probabilistic neural network. Brain Imaging Behav 13:1–24
Glorot X, Bengio Y (2010) Understanding the difficulty of training deep feedforward neural networks. In: Proceedings of the thirteenth international conference on artificial intelligence and statistics, pp 249–256
Golik P, Doetsch P, Ney H (2013) Cross-entropy vs. squared error training: a theoretical and experimental comparison. In: Interspeech, vol 13, pp 1756–1760
Hampel H, Toschi N, Baldacci F, Zetterberg H, Blennow K, Kilimann I, Teipel SJ, Cavedo E, Melo dos Santos A, Epelbaum S et al (2018) Alzheimer’s disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ1-42, total-tau, phosphorylated-tau, nfl, neurogranin, and ykl-40. Alzheimer’s & Dementia 14(4):492–501
Ioffe S, Szegedy C (2015) Batch normalization: accelerating deep network training by reducing internal covariate shift. arXiv:1502.03167
Jain R, Jain N, Aggarwal A, Hemanth DJ (2019) Convolutional neural network based alzheimer’s disease classification from magnetic resonance brain images. Cogn Syst Res 57:147–159
Janocha K, Czarnecki WM (2017) On loss functions for deep neural networks in classification. arXiv:1702.05659
Jo T, Nho K, Saykin AJ (2019) Deep learning in alzheimer’s disease: diagnostic classification and prognostic prediction using neuroimaging data. Front Aging Neurosci 11:220
Kingma DP, Ba J (2014) Adam: A method for stochastic optimization. http://arxiv.org/abs/1412.6980arXiv:1412.6980
LeCun Y, Bengio Y, Hinton G (2015) Deep learning. Nature 521(7553):436–444
Lee B, Ellahi W, Choi JY (2019) Using deep CNN with data permutation scheme for classification of alzheimer’s disease in structural magnetic resonance imaging (SMRI). IEICE Trans Inf Syst 102(7):1384–1395
Liu M, Cheng D, Wang K, Wang Y (2018) Multi-modality cascaded convolutional neural networks for alzheimer’s disease diagnosis. Neuroinformatics 16(3–4):295–308. https://doi.org/10.1007/s12021-018-9370-4
Markesbery WR (2010) Neuropathologic alterations in mild cognitive impairment: a review. J Alzheimers Dis 19(1):221–228
Nakerst G, Brennan J, Haque M (2020) Gradient descent with momentum—to accelerate or to super-accelerate? arXiv:2001.06472
Nwankpa CE, Ijomah W, Gachagan A, Marshall S (2018) Activation functions: comparison of trends in practice and research for deep learning. arXiv:1811.03378
Payan A, Montana G (2015) Predicting alzheimer’s disease: a neuroimaging study with 3d convolutional neural networks. arXiv:1502.02506
Plis SM, Hjelm DR, Salakhutdinov R, Allen EA, Bockholt HJ, Long JD, Johnson HJ, Paulsen JS, Turner JA, Calhoun VD (2014) Deep learning for neuroimaging: a validation study. Front Neurosci 8:229
Prince M, Wimo A, Guerchet M, Ali G, Wu Y, Prina M et al (2019) Alzheimer’s disease international: World alzheimer report 2015: the global impact of dementia: an analysis of prevalence, incidence, cost and trends 2015. Alzheimer’s Disease International, London
Rathore S, Habes M, Iftikhar MA, Shacklett A, Davatzikos C (2017) A review on neuroimaging-based classification studies and associated feature extraction methods for alzheimer’s disease and its prodromal stages. NeuroImage 155:530–548
Rizzi L, Rosset I, Roriz-Cruz M (2014) Global epidemiology of dementia: Alzheimer’s and vascular types. BioMed research international
Samper-Gonzalez J, Burgos N, Bottani S, Fontanella S, Lu P, Marcoux A, Routier A, Guillon J, Bacci M, Wen J et al (2018) Reproducible evaluation of classification methods in alzheimer’s disease: framework and application to MRI and pet data. NeuroImage 183:504–521
Sarraf S, Tofighi G (2016) Deep learning-based pipeline to recognize alzheimer’s disease using FMRI data. In: Future technologies conference (FTC). IEEE, pp 816–820
Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011) Neuropathological alterations in alzheimer disease. Cold Spring Harbor Perspect Med 1(1):a006189
Sørensen L, Igel C, Pai A, Balas I, Anker C, Lillholm M, Nielsen M, Initiative ADN et al (2017) Differential diagnosis of mild cognitive impairment and alzheimer’s disease using structural MRI cortical thickness, hippocampal shape, hippocampal texture, and volumetry. Neuro Image Clin 13:470–482
Teipel SJ, Cavedo E, Lista S, Habert MO, Potier MC, Grothe MJ, Epelbaum S, Sambati L, Gagliardi G, Toschi N et al (2018) Effect of alzheimer’s disease risk and protective factors on cognitive trajectories in subjective memory complainers: an insight-pread study. Alzheimer’s & Dementia 14(9):1126–1136
Vieira S, Pinaya WH, Mechelli A (2017) Using deep learning to investigate the neuroimaging correlates of psychiatric and neurological disorders: Methods and applications. Neurosci Biobehav Rev 74:58–75
Wang S, Wang H, Cheung AC, Shen Y, Gan M (2020) Ensemble of 3d densely connected convolutional network for diagnosis of mild cognitive impairment and alzheimer’s disease. In: Deep learning applications. Springer, pp 53–73
Wang SH, Phillips P, Sui Y, Liu B, Yang M, Cheng H (2018) Classification of alzheimer’s disease based on eight-layer convolutional neural network with leaky rectified linear unit and max pooling. J Med Syst 42(5):85
Wimo A, Guerchet M, Ali GC, Wu YT, Prina AM, Winblad B, Jönsson L, Liu Z, Prince M (2017) The worldwide costs of dementia 2015 and comparisons with 2010. Alzheimer’s & Dementia 13(1):1–7
Zhang Y, Wang S, Sui Y, Yang M, Liu B, Cheng H, Sun J, Jia W, Phillips P, Gorriz JM (2018) Multivariate approach for alzheimer’s disease detection using stationary wavelet entropy and predator-prey particle swarm optimization. J Alzheimers Dis 65(3):855–869
Acknowledgements
Data used in the preparation of this article were obtained from the Alzheimers disease Database Initiative (ADNI) database. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
Yousry AbdulAzeem, Waleed Bahgat, and Mahmoud Badawy declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
AbdulAzeem, Y., Bahgat, W.M. & Badawy, M. A CNN based framework for classification of Alzheimer’s disease. Neural Comput & Applic 33, 10415–10428 (2021). https://doi.org/10.1007/s00521-021-05799-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00521-021-05799-w